Gentherm Reports Mixed 2025 Financials, Cautious 2026 Guidance, and Reiterates Modine Acquisition Details
Summary
Gentherm reported record 2025 revenue but a substantial decline in GAAP net income and EPS, alongside cautious 2026 guidance, while reaffirming its strategic acquisition of Modine's Performance Technologies business.
Key Events
-
Mixed 2025 Financial Performance
Gentherm achieved record annual revenue of $1.5 billion, but reported a significant drop in GAAP net income to $18.3 million for 2025, down from $64.9 million in 2024, with diluted EPS falling to $0.59 from $2.06.
-
Cautious 2026 Guidance and 2027 Outlook
The company provided cautious 2026 revenue guidance of $1.5 billion to $1.6 billion (approximately 3% growth ex-FX) and projected adjusted EBITDA margin expansion of ~30 basis points, with a preliminary 2027 revenue outlook of ~$1.7 billion.
-
Modine Acquisition Update
The presentation reiterated the definitive agreement to acquire Modine's Performance Technologies business, highlighting the creation of a $2.6 billion thermal and flow management leader with approximately $25 million in identified annual cost synergies, expected to close by the end of 2026.
Analysis
This 425 filing provides the detailed presentation slides for Gentherm's fourth quarter and full year 2025 earnings call, offering crucial context to the concurrent 8-K and 10-K filings. While the company achieved record annual revenue, a significant drop in GAAP net income and diluted EPS for 2025, coupled with cautious 2026 guidance, presents a mixed financial picture. However, the presentation also reiterates the strategic importance of the Modine Performance Technologies acquisition, outlining its transformational impact, identified synergies, and long-term growth trajectory. Investors should weigh the short-term financial headwinds against the potential strategic benefits of the acquisition.
At the time of this filing, THRM was trading at $31.31 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $954.5M. The 52-week trading range was $22.75 to $39.48. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.